Ads
related to: tecfidera- GA Mechanism of Action
Learn More About How
Glatiramer Acetate Works
- View Savings and Support
Learn More About Patient Access
and Other Support Options
- GA Mechanism of Action
Search results
Biogen holds onto Tecfidera market in Europe for a little longer
BioPharma Dive via Yahoo Finance· 5 months agoA decision by European regulators to revoke approvals for five generic versions of Biogen's multiple...
If You Invested $25,000 in Biogen in 2018, This Is How Much You Would Have Today
Motley Fool· 1 year agoFive years ago, pharmaceutical manufacturer Biogen (NASDAQ: BIIB) had a growing business, and...
Biogen (BIIB) Beats on Q2 Earnings & Sales, Ups 2022 Guidance
Zacks via Yahoo Finance· 2 years agoBiogen BIIB reported second-quarter 2022 earnings per share (EPS) of $5.25, which significantly beat...
Biogen Inc. (BIIB) Down 2.3% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 1 year agoA month has gone by since the last earnings report for Biogen Inc. (BIIB). Shares have lost about...
Why Is Biogen Inc. (BIIB) Up 6.4% Since Last Earnings Report?
Zacks via Yahoo Finance· 5 months agoA month has gone by since the last earnings report for Biogen Inc. (BIIB). Shares have added about...
US Supreme Court Turns Away Biogen's Last Effort To Reinstate Tecfidera Patent
Benzinga via Yahoo Finance· 2 years agoThe U.S. Supreme Court decided not to hear the case related to reinstating the patent of Biogen...
U.S. Supreme Court turns away Biogen bid to reinstate MS drug patent
Reuters via Yahoo News· 2 years agoWASHINGTON (Reuters) -The U.S. Supreme Court on Monday declined to hear Biogen Inc's bid to win...
Biogen (BIIB) Q4 Earnings & Sales Miss Estimates, Stock Falls
Zacks via Yahoo Finance· 3 months agoBiogen BIIB reported fourth-quarter 2023 adjusted earnings per share (EPS) of $2.95, which missed...
Europe revokes marketing authorization for generic versions of Biogen's MS drug
Reuters via AOL· 5 months agoWhile the patent for Biogen's drug has expired in the United States, it had scored a win in Europe...
Will Biogen (BIIB) Beat Estimates This Earnings Season?
Zacks via Yahoo Finance· 1 year agoWe expect Biogen BIIB to beat expectations when it reports fourth-quarter and full-year 2022 results...
Ads
related to: tecfidera
